Navigation Links
New targeted therapy effective in treating advanced prostate cancer
Date:4/14/2010

An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC), known for its poor prognosis and limited treatment options. The research, led by investigators at Memorial Sloan-Kettering Cancer Center, appears early online and in an upcoming edition of The Lancet.

According to the findings of the Phase 1-2 study, MDV3100 not only shrank patients' tumors, but also reduced serum levels of the tumor marker prostate-specific antigen (PSA), stabilized disease that had spread to soft tissues and the bone, and reduced the number of circulating tumor cells in the blood.

"We were encouraged to see antitumor activity in men whose disease had spread to other parts of the body after either becoming resistant to previous hormone treatments or progressing following chemotherapy," said the study's lead author Howard Scher, MD, Chief of the Genitourinary Oncology Service at Memorial Sloan-Kettering. "These findings strengthen the drug's potential to change the outlook for a group of patients who currently have limited effective treatment options from which to choose."

According to the research, MDV3100 slows tumor growth and induces tumor cells to die in men with CRPC, or hormone-refractory disease, which depends on male hormones to grow, but is unresponsive or becomes resistant to standard therapies used to lower or block those hormones. MDV3100 works by blocking testosterone from binding to the androgen (male hormone) receptor, stopping the movement of the androgen receptor to the nucleus of prostate cancer cells, preventing the receptor from binding to DNA, and inducing cancer cell death, even when the expression of the androgen receptor is elevated.

"This study validates what our preclinical studies have suggested: that sustained androgen
'/>"/>

Contact: Jeanne DAgostino
dagostij@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Kaiser Permanente Southern California to Offer FitOrbit Online Personal Training to Targeted Patients
2. Targeted agent blocked growth of deadly brain cancer in preclinical studies
3. Survival in metastatic breast cancer patients is improving: targeted therapies have contributed
4. Gene-Targeted Cancer Fix Could Be a Breakthrough
5. Targeted delivery of losartan reduces liver inflammation and scarring
6. Targeted prevention stopped spread of H1N1 at Alabama boys camp
7. Human Touch Introduces New CirQlation™ Elite Foot & Calf Massager Providing Ultimate Targeted Relief for Tired Feet and Calves
8. Middle Schoolers Identify Violent Content in Youth-Targeted Entertainment as a Strong Influence in Causing Youth Violence
9. Targeted therapy prolongs life in patients with HER2-positive breast cancer
10. Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty
11. Targeted breast ultrasound can reduce biopsies for women under 40
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Francisco, California (PRWEB) November 24, 2014 ... reach USD 6.19 billion by 2020, according to ... Increasing incidence rates of cardiac arrhythmias clubbed with ... drivers of this market. Though still in the ... a significant rise in usage rates in the ...
(Date:11/24/2014)... 2014 Volpara Solutions announced today ... the 100th Annual Meeting of the Radiology Society ... (RSNA Booth 1752 – South Hall). Volpara Solutions ... the rest of its innovative suite of quantitative ... enable personalized measurements of volumetric density, patient-specific dose, ...
(Date:11/24/2014)... November 24, 2014 Residents of retirement ... in this year’s SENIORS GOT TALENT, an annual online ... From piano players to classic crooners, to seniors partying ... older adults are indeed living young. , “SENIORS GOT ... there’s a cash prize, has always been about highlighting ...
(Date:11/24/2014)... Olaparib functions as a chemical of ... one of the first PARP inhibitors. Sufferers with BRCA1/2 ... of melanoma, and are often immune to other types ... malignancies a exclusive weaknesses, as the tissues of melanoma ... and allow them to proceed splitting. This implies that ...
(Date:11/24/2014)... The Holiday Inn Westbury - Long Island ... Association to donate various items consisting of practical, ... such items.The Association's program is aimed toward helping over ... nursing homes, assisted living facilities and nursing homes. The ... of seniors throughout the Long Island area. The Holiday ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 2Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 3Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 2Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 4Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3
... available in Spanish . Researchers headed ... New York and by Mara Macas at the Institute for ... by which some proteins that are essential for life, called ... fruit of three years of intense work, the study reports ...
... Institute (JASRI) have successfully produced a first beam of ... This light was created using SACLA, a cutting-edge X-ray ... February 2011 in Harima, Japan. SACLA (SPring-8 Angstrom Compact ... of atoms and molecules at a level of detail ...
... By Alan Mozes HealthDay Reporter , THURSDAY, June ... exercise habits of America,s teens, new data from the U.S. ... picture. Not only are high school kids guzzling far ... the CDC research team found. In fact, just one ...
... steady reduction in overall cancer death rates translates to ... 1990 and 2007, according to the latest statistics from ... 2011, and its companion consumer publication Cancer Facts & ... segments of the population equally. A special section of ...
... A team of social scientists and medical and nursing ... has pinpointed how a programme, which ran in more ... reduced the rates of potentially deadly central line bloodstream ... patient safety programmes. Funded in part by the ...
... Child Development (e-publication ahead of print) finds ... lead to a mathematical learning disability and difficulty in ... just one cause of math learning disabilities, according to ... Kennedy Krieger Institute. Approximately 6 to 14 percent ...
Cached Medicine News:Health News:Discovery of a new mechanism of gene control that is associated with cancer 2Health News:First X-ray lasing of SACLA 2Health News:High School Kids Get Too Many Sugary Drinks, Too Little Exercise: CDC 2Health News:High School Kids Get Too Many Sugary Drinks, Too Little Exercise: CDC 3Health News:American Cancer Society report finds continued progress in reducing cancer mortality 2Health News:American Cancer Society report finds continued progress in reducing cancer mortality 3Health News:American Cancer Society report finds continued progress in reducing cancer mortality 4Health News:International team works out secrets of one of world's most successful patient safety programs 2Health News:International team works out secrets of one of world's most successful patient safety programs 3Health News:Poor 'gut sense' of numbers contributes to persistent math difficulties 2Health News:Poor 'gut sense' of numbers contributes to persistent math difficulties 3
(Date:11/24/2014)... YORK , Nov. 24, 2014  AiCure, ... and motion-sensing technology to monitor medication ingestion, has ... to monitor and intervene with patients receiving medication ... Fatal overdoses from prescription opiates have quadrupled ... more deaths per year than heroin, cocaine and ...
(Date:11/24/2014)... , Nov. 24, 2014  Rigel Pharmaceuticals, Inc. (Nasdaq: ... is retiring from the board of directors and from ... Raul Rodriguez , most recently serving as the company,s president ... executive officer and join the board of directors.  Gary ... 2005, will become chairman. Mr. Gower is expected to remain ...
(Date:11/24/2014)... PLYMOUTH MEETING, Pa. , Nov. 24, 2014  Inovio ... Dr. J. Joseph Kim , President and CEO of ... board and management team to ring the Nasdaq Opening Bell ... celebration of Inovio,s September 15 th listing on the ... bell ringing ceremony, Dr. Kim said, "We are honored to ...
Breaking Medicine Technology:Can artificial intelligence solve the $55 billion problem of opioid abuse? 2Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3
... Taylor Strategy Partners (TSP), who enable clients in the life science ... organizations, is pleased to announce the expansion of its operations to ... is headquartered in Columbus, OH with additional offices in New York, ... Director, will be taking the lead of the Kansas City office. ...
... Friday, June 10, 2011 at twelve o,clock noon, NMT ... Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm ... the benefit of NMT Medical creditors. ... that designed, developed, manufactured and marketed proprietary implant technologies ...
Cached Medicine Technology:Taylor Strategy Partners Set to Open Office in Kansas City in June 2011 2NMT Medical, Inc. Sealed Bid Sale of its Intellectual Property to Take Place Friday, June 10, 2011 at Twelve O'Clock Noon 2
... a cast from an arm or leg can ... cut or burned by the cast saw blade. ... remove any cast with confidence. This innovative, cut-resistant ... burns from the cast saw and can be ...
... bypass grafting or creation of a vascular ... tunnel is of the utmost importance in ... answer for those seeking a high-precision tunneling ... the risk of twisting or kinking for ...
... In pediatric cardiac surgery, modified Blalock-Taussig ... prior to total correction. GORE-TEX Vascular Grafts ... of surgeons worldwide for use as shunts ... offer such benefits as ease of implantation ...
... have met the challenges of the most ... Recognized for exceptional performance and quality, they ... worldwide. These grafts require no preclotting, resist ... assure utmost thrombectomy safety. The Gore vascular ...
Medicine Products: